Morepen Laboratories Limited (NSE:MOREPENLAB)

Morepen Laboratories Statistics

Total Valuation

NSE:MOREPENLAB has a market cap or net worth of INR 35.13 billion. The enterprise value is 35.22 billion.

Market Cap	35.13B
Enterprise Value	35.22B

Important Dates

The next estimated earnings date is Thursday, August 7, 2025.

Earnings Date	Aug 7, 2025
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	547.95M
Shares Outstanding	n/a
Shares Change (YoY)	+4.95%
Shares Change (QoQ)	+6.57%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	307.37M

Valuation Ratios

The trailing PE ratio is 29.77.

PE Ratio	29.77
Forward PE	n/a
PS Ratio	1.92
PB Ratio	2.96
P/TBV Ratio	3.48
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 18.30, with an EV/FCF ratio of -38.29.

EV / Earnings	29.84
EV / Sales	1.92
EV / EBITDA	18.30
EV / EBIT	21.55
EV / FCF	-38.29

Financial Position

The company has a current ratio of 2.32, with a Debt / Equity ratio of 0.09.

Current Ratio	2.32
Quick Ratio	0.90
Debt / Equity	0.09
Debt / EBITDA	0.55
Debt / FCF	-1.14
Interest Coverage	19.59

Financial Efficiency

Return on equity (ROE) is 11.60% and return on invested capital (ROIC) is 9.42%.

Return on Equity (ROE)	11.60%
Return on Assets (ROA)	6.65%
Return on Invested Capital (ROIC)	9.42%
Return on Capital Employed (ROCE)	12.80%
Revenue Per Employee	8.50M
Profits Per Employee	548,422
Employee Count	2,152
Asset Turnover	1.19
Inventory Turnover	4.37

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +43.68% in the last 52 weeks. The beta is 0.79, so NSE:MOREPENLAB's price volatility has been lower than the market average.

Beta (5Y)	0.79
52-Week Price Change	+43.68%
50-Day Moving Average	57.97
200-Day Moving Average	69.77
Relative Strength Index (RSI)	55.69
Average Volume (20 Days)	5,981,965

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, NSE:MOREPENLAB had revenue of INR 18.30 billion and earned 1.18 billion in profits. Earnings per share was 2.20.

Revenue	18.30B
Gross Profit	6.30B
Operating Income	1.63B
Pretax Income	1.55B
Net Income	1.18B
EBITDA	1.92B
EBIT	1.63B
Earnings Per Share (EPS)	2.20

Balance Sheet

The company has 1.27 billion in cash and 1.05 billion in debt, giving a net cash position of 220.72 million.

Cash & Cash Equivalents	1.27B
Total Debt	1.05B
Net Cash	220.72M
Net Cash Per Share	n/a
Equity (Book Value)	11.87B
Book Value Per Share	19.92
Working Capital	6.59B

Cash Flow

In the last 12 months, operating cash flow was 320.57 million and capital expenditures -1.24 billion, giving a free cash flow of -919.76 million.

Operating Cash Flow	320.57M
Capital Expenditures	-1.24B
Free Cash Flow	-919.76M
FCF Per Share	n/a

Margins

Gross margin is 34.43%, with operating and profit margins of 8.93% and 6.45%.

Gross Margin	34.43%
Operating Margin	8.93%
Pretax Margin	8.48%
Profit Margin	6.45%
EBITDA Margin	10.52%
EBIT Margin	8.93%
FCF Margin	n/a

Dividends & Yields

NSE:MOREPENLAB does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-4.95%
Shareholder Yield	n/a
Earnings Yield	3.36%
FCF Yield	-2.62%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

The last stock split was on November 6, 2000. It was a forward split with a ratio of 5.

Last Split Date	Nov 6, 2000
Split Type	Forward
Split Ratio	5

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a